Effectiveness and safety of the amivantamab to lazertinib versus lazertinib alone in EGFR mutant metastatic non-small-cell lung cancer: Systematic review and meta-analysis.
Authors: Shatha Elemian, Ahmad Habbas, Laith Sorour, Munther Hamad, Tasneem Anagreh, Noor Isbeih, Samer Jumean